FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,841 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,860

 

Start Prev Rows 8800 - 9000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1078.17Atrial fibrillationactive2024-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.45ACE inhibitor allergy RXNORMactive2024-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.94Albuminuria SCTactive2024-07hl7sct
us.nlm.vsacR42.16.840.1.113883.11.20.9.35Pressure Ulcer Stageactive2023-07hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.1037Risk Categoryactive2008-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7966Rodent Type (Leptospirosis)active2020-01sct tho
hl7.fhir.us.vrdrR4vrdr-transportation-incident-role-vsTransportation Incident Role ValueSetactivepher2024-10hl7sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.977Contact Roleactive2008-01tho oid
us.cdc.phinvadsR42.16.840.1.113883.3.88.12.3221.8.7Medication Route FDA Value Setactive2014-01
us.cdc.phinvadsR42.16.840.1.114222.4.11.7694Administration Route (RIBD)active2018-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3132Lab Result (Rubella)active2008-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3127Genotype (Rubella)active2017-01sct tho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.320Opioids ATCPROD N02Aactive2024-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.473Tetanus toxoid, diphtheria (Td) Vaccineactive2023-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.569Allergen Immunotherapyactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.976Ensifentrineactive2025-01hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.977Dupilumabactive2025-01hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1213.106Cytochrome P450 2C9 inhibitorsactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.478Allergy to HPV Vaccineactive2023-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.570Allergy to house dust mites SCTactive2023-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.618relatedconditions_Asthma SCTactive2023-09hl7sct
hl7.fhir.us.vitalsR4BodyTempAssociatedSituationVSBody Temperature Associated Situation value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4BodyWeightAssociatedSituationVSAssociated Situation value setdraft2024-10hl7fhir sct
hl7.fhir.us.vitalsR4bodyTempMeasurementDeviceVSBody Temperature Measurement Device value setdraft2024-10hl7fhir sct
hl7.fhir.us.vitalsR4exertionPhaseVSExertion Phase value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4exertionPhaseVSExertion Phase value setdraft2023-08hl7sct
hl7.fhir.us.vitalsR4MeasSettingVSMeasurement Setting value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4MeasSettingVSMeasurement Setting value setdraft2023-08hl7sct
hl7.fhir.us.vitalsR4sleepStatusVSSleep Status value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4sleepStatusVSSleep Status value setdraft2023-08hl7sct
hl7.fhir.us.vitalsR4weightMeasurementDeviceVSWeight Measurement Device value setdraft2024-10hl7fhir sct
hl7.fhir.us.vitalsR4bpMeasMethodVSBlood Pressure Measurement Method value setdraft2024-10hl7fhir sct
hl7.fhir.us.cardx-htnR4bpMeasMethodVSBlood Pressure Measurement Method value setdraft2023-08hl7fhir sct
hl7.fhir.us.vitalsR4heartRateMeasMethodVSHeart Rate Measurement Method value setdraft2024-10hl7fhir sct
hl7.fhir.us.cardx-htnR4heartRateMeasMethodVSHeart Rate Measurement Method value setdraft2023-08hl7fhir sct
hl7.fhir.us.vitalsR4heightLengthMeasMethodVSHeight Length Measurement Method value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4respiratoryRateMeasMethodVSRespiratory Rate Measurement Method value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4respiratoryRateMeasDeviceVSRespiratory Rate Measurement Device value setdraft2024-10hl7fhir sct
hl7.fhir.us.vitalsR4heightLengthMeasDeviceVSHeight Length Measurement Device value setdraft2024-10hl7fhir sct
hl7.fhir.us.vitalsR4heartRateMeasDeviceVSHeart Rate Measurement Device value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4heartRateMeasDeviceVSHeart Rate Measurement Device value setdraft2023-08hl7sct
hl7.fhir.us.vitalsR4bpMeasDeviceVSBlood Pressure Measurement Device value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4sensorDescriptionVSSensor Description value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4bpmeasbodylocationprecoordBlood Pressure Measurement Body Location Precoordinated value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4bpmeasbodylocationprecoordBlood Pressure Measurement Body Location Precoordinated value setdraft2023-08hl7sct
hl7.fhir.us.vitalsR4heightBodyPositionVSHeight Body Position value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4bpCuffSizeVSBlood Pressure Cuff Size value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4heartRateMeasBodyLocationPrecoordVSHeart Rate Measurement Body Location Precoordinated value setdraft2024-10hl7fhir sct
hl7.fhir.us.cardx-htnR4heartRateMeasBodyLocationPrecoordVSHeart Rate Measurement Body Location Precoordinated value setdraft2023-08hl7fhir sct
hl7.fhir.us.vitalsR4bodyTempMeasBodyLocationPrecoordVSBody Temperature Measurement Body Location value setdraft2024-10hl7sct
hl7.fhir.us.vitalsR4bodyPositionVSBody Position value setdraft2024-10hl7sct
hl7.fhir.us.cardx-htnR4bodyPositionVSBody Position value setdraft2023-08hl7sct
hl7.fhir.us.vitalsignsR4bodyWeightMeasurementAssociatedPrecondVSBody Weight Measurement Associated Precondition value setdraft2019-05hl7sct
hl7.fhir.us.vitalsignsR4bpMeasDeviceCSVSBlood Pressure Measurement Device and Cuff Size value setdraft2019-05hl7fhir sct
hl7.fhir.us.vitalsignsR4clothingWornDuringMeasureVSClothing Worn During Measure value setdraft2019-09hl7fhir sct
hl7.fhir.us.vitalsignsR4bodyTempMeasMethodDeviceVSBody Temperature Measurement Method Device value setdraft2019-05hl7fhir sct
hl7.fhir.us.vitalsR4WeightUOMVSWeight Units of Measure value setdraft2024-10hl7ucum
hl7.fhir.us.vitalsR4TemperatureUOMVSTemperature Units of Measure value setdraft2024-10hl7ucum
hl7.fhir.us.vitalsR4LengthUOMVSLength Units of Measure value setdraft2024-10hl7ucum
fhir.tx.support.r4R4snomed-intl-ipsSNOMED CT® International Patient Set (IPS)active2022-06hl7sct
us.nlm.vsacR42.16.840.1.113883.3.88.12.80.28Procedureactive2024-06hl7sct
hl7.fhir.us.qicoreR4qicore-observation-body-positionQICore Observation Body Positionactivecqi2018-08hl7sct
hl7.fhir.us.registry-protocolsR4PriorMyocardialInfarctionPrior Myocardial Infarctionactivecic2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.516Allergy to Herpes Zoster Vaccine SCTactive2023-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.25Attention Deficit and Hyperactivity Disorderactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.22Acute Kidney Injuryactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.38Coronary Artery Diseaseactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.39Chronic Kidney Diseaseactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.40Chronic Obstructive Pulmonary Diseaseactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.33Failure to Thriveactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.31Parkinson's Disease and Parkinsonismactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.23Anemiaactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.24Cardiac Arrhythmiasactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.26Cerebrovascular Diseaseactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.41Diabetes Mellitusactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.36Dyslipidemiaactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.37Heart Failureactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.12Hypertensionactive2022-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.35Mood Disordersactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.34Osteoporosisactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.28Proteinuriaactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.27Seizure Disorderactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.30Thromboembolic Diseaseactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.29Thyroid Hormone Disorderactive2023-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1251.32Upper GI Diseasesactive2023-10hl7sct
hl7.fhir.us.registry-protocolsR4CardiacCatheterSNOMED Cardiac Cathetersactivecic2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1237.12SNOMEDFindingValuesQualifierValueactive2024-01hl7sct
hl7.fhir.us.registry-protocolsR4PackedRedBloodCellsPacked Red Blood Ceelsactivecic2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.178Intubationactive2023-05hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.180Tracheostomy Proceduresactive2024-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.182Head and Neck Surgeries with High Risk Airway Compromiseactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.85Elective Inpatient Encounteractive2023-05hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.240Degenerative Neurological Disorderactive2024-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1248.238Neuromuscular Disorderactive2023-09hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.1092Hemorrhagic Illness Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.1093Localized Cutaneous Lesion Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7735SPN/IPD Serotype (RIBD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7934Microorganism (STD)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3056STORET Chemicals (EPA)active2008-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7712School Year (RIBD)active2018-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7864Specimen Source (C. auris)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7637Seafood Preparation (FDD)active2018-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7638Seafood Source (FDD)active2017-01tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1146.181Coccidioidomycosis (Disorders) (SNOMED)active2024-01hl7sct
us.nlm.vsacR42.16.840.1.113883.1.11.20.22HPDocumentTypeactive2025-04hl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.9.31ConsultDocumentTypeactive2025-03hl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.6.1ProcedureNoteDocumentTypeCodesactive2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.4.1DischargeSummaryDocumentTypeCodeactive2024-06hl7loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7490Clinical Syndrome - Secondary (Arbovirus)active2016-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7332Setting of Further Spreadactive2015-01sct tho oid
hl7.fhir.us.splR5splSectionCodesSPL Section Codestrial-use1brr2025-07hl7loinc
fhir.acme.affiliate-reportR4section-type-vsSection Type ValueSetdraft2025-05hl7internal
hl7.fhir.us.ndhR4NdhSecureExchangeArtifactsVSSecure Exchange Artifacts Value Settrial-usepa2025-07hl7fhir
us.nlm.vsacR42.16.840.1.113883.11.20.9.29DIRQuantityMeasurementTypeCodesactive2024-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4periwoundConditionVSReriwoundConditionvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundBedAppearanceVSWoundBedAppearanceValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundAssessmentInterpretationVSWoundAssessmentInterpretationvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundTypeEtiologyVSWoundTypeEtiologyvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundGradationVSWoundGradationValueSetdraft2019-06hl7sct
hl7.fhir.us.vitalsR4definedLimitsVSDefined Limits value setdraft2024-10hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4clockFacePositionVSClockFacePositionValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateOdorVSWoundExudateOdorValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4presentAbsentVSPresentAbsentValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4episodeVSEpisodevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4trendVSTrendvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundInternalItemOrBodyStructureVisibleVSWoundInternalItemOrBodyStructureVisiblevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundEdgeDescriptionVSWoundEdgeDescriptionValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateColorVSWoundExudateColorValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateAppearanceVSWoundExudateAppearanceValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundMeasurementDeviceVSWoundMeasurementDeviceValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundBedColorVSWound Bed Color value setdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundEdgeColorVSWoundEdgeColorValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundShapeVSWound Shape value setdraft2019-09hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateAmountDescriptionVSWoundExudateAmountDescriptionValueSetdraft2019-06hl7sct
hl7.fhir.us.vitalsR4sPO2BodyLocationVSOxygen Saturation Body Location value setdraft2024-10hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4courseVSCoursevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLocationQualifierVSBodyLocationQualifiervaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundTypeVSCIMIWoundTypevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLocationOrientationVSBodyLocationOrientationvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4underlyingAnatomicalStructureVSUnderlyingAnatomicalStructurevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4pressureUlcerAssociationVSPressureUlcerAssociationvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodySideVSBodySidevaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4qualitativeWoundDepthVSQualitativeWoundDepthvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundAnatomicLocationVSWoundAnatomicLocationvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4yesNoVSYesNoValueSetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4surfaceOrientationVSSurfaceOrientationvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLandmarkDescriptionVSBodyLandmarkDescriptionvaluesetdraft2019-06hl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4recurrenceVSRecurrencevaluesetdraft2019-06hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7959Underlying Condition(s) (Leptospirosis)active2020-01sct tho
signal.core.r4R4questionnaire-ccars-sexual-orientationQuestionnaire CCARS Sexual Orientationdraft1pahl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.1103Semantic Clinical Drug (Ingredient plus strength and dose form)active2020-01rx
us.cdc.phinvadsR42.16.840.1.114222.4.11.1104Semantic Clinical Drug Form (Ingredient plus dose form)active2020-01rx
hl7.fhir.us.davinci-drug-formularyR4SemanticDrugFormGroupVSSemantic Drug Form Group Codestrial-usephx2025-02hl7rx
hl7.fhir.us.davinci-drug-formularyR4NonPackSemanticDrugVSNon-Pack Semantic Drug Codestrial-usephx2025-02hl7rx
hl7.fhir.us.davinci-drug-formularyR4SemanticDrugVSSemantic Drug Codestrial-usephx2025-02hl7fhir rx
hl7.fhir.us.military-serviceR4military-service-separation-reason-vsSeparation Reason Value Setactive2023-05hl7fhir
us.nlm.vsacR42.16.840.1.113762.1.4.1290.5Septic Shockactive2025-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1290.6Septic Shockactive2025-04hl7icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7706Sequelae (RIBD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7773Serogroup Method (RIBD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7736Serotype Method (RIBD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3320Serotype Method (IPD)active2010-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7477Positive Negative 4 Fold Rise Not Doneactive2016-01sct oid
fhir.nigeriaImmunizationR4neir-service-request-vsNGTSSVSRQTSactive2025-05hl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.3227Location performing blood or body fluid exposure procedureactive2009-01tho
hl7.fhir.us.breast-radiologyR4ServiceRecommendationsVSServiceRecommendations ValueSetactive2022-12hl7fhir
hl7.fhir.us.ecrR4valueset-ersd-endpoint-connection-typeeRSD Endpoint Connection Type Codesactive2020-08hl7fhir tho
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1077Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.304Pesticide Related Illness (Disorders) (SNOMED)active2023-01hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7807Bird Exposure Setting (RIBD)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7634Sexual Contact (FDD)active2017-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3231Disease Type (STD)active2009-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7639Shellfish Distributed (FDD)active2017-01tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1235.619b.well Herpes Zoster Vaccine CN_HD_SNOMEDactive2025-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.561Oral Steroid for Cluster Headacheactive2023-12hl7rx
us.cdc.phinvadsR42.16.840.1.114222.4.11.7965Sick Animal Type (Leptospirosis)active2020-01sct tho
fhir.cdc.opioid-cds-r4R4sickle-cell-diseasesSickle-cell diseasesactive2023-05hl7sct icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7771Side Effect Time to Onset (TB)active2017-12oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7772Side Effect of Treatment (TB)active2018-01sct tho oid
signal.core.r4R4signal-organization-licenseSignal Organization Licensedraft2023-07hl7
signal.core.r4R4signal-organization-qualificationSignal Organization Qualificationdraft1pahl7
signal.core.r4R4signal-healthcare-service-typeSignal Healthcare Service Typedraft1pahl7
signal.core.r4R4signal-regionSignal Regiondrafthl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7662Signs and Symptoms (Measles)active2018-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7283Signs and Symptoms (Mumps)active2015-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7284Signs and Symptoms (Pertussis)active2017-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3240Flu Signs and Symptomsactive2009-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7460Signs Symptoms (Arbovirus)active2016-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7482Signs Symptoms (Chikungunya)active2016-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7481Signs Symptoms (Dengue)active2016-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7459Signs Symptoms (Zika)active2016-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7225Signs Symptoms (CS)active2020-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7723Signs and Symptoms (RIBD)active2018-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7666Signs and Symptoms (Trich)active2018-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7944Signs and Symptoms (COVID-19)active2021-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8059Signs and Symptoms (Hepatitis)active2021-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7649Signs and Symptoms (Rubella)active2018-01sct tho
hl7.fhir.us.directory-queryR4NetworkTypeVSNetwork Type Value Setactive2022-12hl7fhir
hl7.fhir.us.davinci-pdex-plan-netR4NetworkTypeVSNetwork Type VStrial-usefm2025-02hl7fhir
hl7.fhir.us.ndhR4NetworkTypeVSNetwork Type Value Settrial-usepa2025-07hl7tho